Show results for
Refine by
Biomarker Services In France
14 services found
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
From our proprietary biomarkers, our innovated assays solutions, our unique data analysis platforms and our CDx development capabilities, we offer a comprehensive family of biomarker services that enhance your insight into the tumor microenvironment ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Leverage the widely used Nanostring platform to study gene expression in the tumor microenvironment, revealing biomarker signatures, mechanism of action, disease biology, and more. The most popular Nanostring service we offer is the nCounter® PanCancer IO 360™ Panel. This panel is designed to deliver immuno-oncology insights for translational research and assesses the ...
Manufactured by:Firalis Group based inHuningue, FRANCE
Firalis has extensive experience in data analysis and utilizes innovative techniques to identify novel biomarker candidates for diagnostics, patient stratification and follow-up or treatment response. Our statistical department can support your projects with the analysis and integration of multidimensional data through the lifecycle of your clinical studies from the experimental ...
Manufactured by:Firalis Group based inHuningue, FRANCE
The successful implementation of a biomarker endpoint is highly dependent on the availability of assays and on reliable measurements of markers in biological samples. While a large number of assays are on the market, scientists often have an urgent need for assays meeting specific ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Veracyte has large capacity, high-throughput RNA-seq capabilities that speed turnaround-time for your studies. Our RNA-seq Services team can run your study using Illumina’s AmpliSeq and TruSight kits, or we can build a custom gene expression analysis panel to advance your project goals. As with all of our services, Veracyte provide detailed bioinformatic analysis and interpretation, to ...
by:Novadiscovery based inLyon, FRANCE
Explore various regimens (dose, number of administrations per day, time between administrations, duration of treatment). Identify subgroups of optimal responders / theranostic biomarkers. Leverage real-world data to inform clinical trial ...
Manufactured by:Ariana Pharma based inParis, FRANCE
Thanks to our XAI KEM® platform we integrate extensive pre-clinical, clinical as well as Real World Evidence data, to define best dose, identify patient selection and surrogate endpoint biomarkers as well as alternative clinical indications. Our Precision Medicine clinical protocols allow for extensive data collection and use of stratification biomarkers, ...
by:Appolon Bioteck based inBrignais, FRANCE
Companion diagnostics is becoming a key element in cancer treatment. New predictive biomarkers and molecular strategies for personalized cancer therapies are currently available to treat each individual patient depending on the genetic characteristics of its tumor. Apollon Bioteck manufactures and promotes ready to use IVD assays for companion Diagnostics. ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Immunogram, Veracyte’s advanced analytics platform, integrates multi-omic data sets and analyzes them into a single per patient view of key biomarker signatures, specific to their own Tumor Microenvironment. This analytics platform delivers valuable insights to improve patient care and help clinical researchers make informed decisions to advance therapeutic and ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Veracyte’s Cancer Immune Atlas allows clinical researchers to maximize the value of the data generated through our Immunogram analysis platform. The Cancer Immune Atlas creates a reference database from individual Immunograms, to generate biomarker maps, assess toxicity and drug response, stratify patients, and develop predictive ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Advances in molecular and imaging techniques have resulted in an explosion of data, providing an unprecedented opportunity to identify clinically relevant drug targets. Yet, deciphering and extracting subtle biomarker signatures from multiple data modalities and sources remains challenging. The cloud-based and decentralized SOPHiA DDM™ Platform integrates data and ...
by:SeqOne S.A.S. based inMontpellier, FRANCE
Genetic cancer analyses are particularly challenging due to the huge number of de novo variants and the need to combine DNA and RNA data in some cases. This requires a unique set of interpretation tools and specifically tuned ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Veracyte’s professional framework for clinical trial assay (CTA) and companion diagnostics (CDx) development allows our clients to confidently advance priority projects. With an end-to-end service infrastructure, we support all aspects of assay development, manufacturing, life cycle management, regulatory submissions, marketing support, and commercialization for our ...
Manufactured by:Firalis Group based inHuningue, FRANCE
Firalis biobank facilities are an ideal option for long-term storage of your biospecimens. Our regulatory compliant storage facilities are operated by high competent staff under a strict quality management and control policy ensuring a high standard of ...